These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32791825)

  • 1. Rational Design of a Robust Antibody-like Small-Molecule Inhibitor Nanoplatform for Enhanced Photoimmunotherapy.
    Shang Q; Zhou S; Jiang Y; Wang D; Wang J; Song A; Luan Y
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40085-40093. PubMed ID: 32791825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade.
    Tu K; Yu Y; Wang Y; Yang T; Hu Q; Qin X; Tu J; Yang C; Kong L; Zhang Z
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39003-39017. PubMed ID: 34433253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PCC0208025 (BMS202), a small molecule inhibitor of PD-L1, produces an antitumor effect in B16-F10 melanoma-bearing mice.
    Hu Z; Yu P; Du G; Wang W; Zhu H; Li N; Zhao H; Dong Z; Ye L; Tian J
    PLoS One; 2020; 15(3):e0228339. PubMed ID: 32214351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Three-in-One Immunotherapy Nanoweapon via Cascade-Amplifying Cancer-Immunity Cycle against Tumor Metastasis, Relapse, and Postsurgical Regrowth.
    Li Q; Zhang D; Zhang J; Jiang Y; Song A; Li Z; Luan Y
    Nano Lett; 2019 Sep; 19(9):6647-6657. PubMed ID: 31409072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
    Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
    Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 Blockade for Improving the Antitumor Efficiency of Polymer-Doxorubicin Nanoprodrug.
    Gao F; Zhang C; Qiu WX; Dong X; Zheng DW; Wu W; Zhang XZ
    Small; 2018 Sep; 14(37):e1802403. PubMed ID: 30129176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
    Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
    J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Redox-Triggered Autophagy-Induced Nanoplatform with PD-L1 Inhibition for Enhancing Combined Chemo-Immunotherapy.
    Li M; Zhao D; Yan J; Fu X; Li F; Liu G; Fan Y; Liang Y; Zhang X
    ACS Nano; 2024 May; 18(20):12870-12884. PubMed ID: 38727063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser Immunotherapy in Combination with Perdurable PD-1 Blocking for the Treatment of Metastatic Tumors.
    Luo L; Zhu C; Yin H; Jiang M; Zhang J; Qin B; Luo Z; Yuan X; Yang J; Li W; Du Y; You J
    ACS Nano; 2018 Aug; 12(8):7647-7662. PubMed ID: 30020768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
    Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
    Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor.
    Tan YN; Li YP; Huang JD; Luo M; Li SS; Lee AW; Hu FQ; Guan XY
    Cancer Lett; 2021 Dec; 522():238-254. PubMed ID: 34571084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating Immunologically Cold Tumors by Precise Cancer Photoimmunotherapy with an Extendable Nanoplatform.
    Yu W; Sun J; Liu F; Yu S; Hu J; Zhao Y; Wang X; Liu X
    ACS Appl Mater Interfaces; 2020 Sep; 12(36):40002-40012. PubMed ID: 32805869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl/thiolated chitosan nanoparticles suppresses cancer progression in tumor-bearing mice.
    Bastaki S; Aravindhan S; Ahmadpour Saheb N; Afsari Kashani M; Evgenievich Dorofeev A; Karoon Kiani F; Jahandideh H; Beigi Dargani F; Aksoun M; Nikkhoo A; Masjedi A; Mahmoodpoor A; Ahmadi M; Dolati S; Namvar Aghdash S; Jadidi-Niaragh F
    Life Sci; 2021 Feb; 266():118847. PubMed ID: 33309720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?
    Chen T; Li Q; Liu Z; Chen Y; Feng F; Sun H
    Eur J Med Chem; 2019 Jan; 161():378-398. PubMed ID: 30384043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
    Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
    Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosome activable polymeric vorinostat encapsulating PD-L1KD for a combination of HDACi and immunotherapy.
    Lu F; Hou L; Wang S; Yu Y; Zhang Y; Sun L; Wang C; Ma Z; Yang F
    Drug Deliv; 2021 Dec; 28(1):963-972. PubMed ID: 34036867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-responsive and self-targeting assembly from hyaluronic acid-based conjugate toward all-in-one chemo-photodynamic therapy.
    Wu J; Hu X; Liu R; Zhang J; Song A; Luan Y
    J Colloid Interface Sci; 2019 Jul; 547():30-39. PubMed ID: 30933691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobubbles Containing sPD-1 and Ce6 Mediate Combination Immunotherapy and Suppress Hepatocellular Carcinoma in Mice.
    Tan Y; Yang S; Ma Y; Li J; Xie Q; Liu C; Zhao Y
    Int J Nanomedicine; 2021; 16():3241-3254. PubMed ID: 34007176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cold to Hot: Rational Design of a Minimalist Multifunctional Photo-immunotherapy Nanoplatform toward Boosting Immunotherapy Capability.
    Zhang D; Zhang J; Li Q; Song A; Li Z; Luan Y
    ACS Appl Mater Interfaces; 2019 Sep; 11(36):32633-32646. PubMed ID: 31429272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size-optimized nuclear-targeting phototherapy enhances the type I interferon response for "cold" tumor immunotherapy.
    Zhang X; Yi C; Zhang L; Zhu X; He Y; Lu H; Li Y; Tang Y; Zhao W; Chen G; Wang C; Huang S; Ouyang G; Yu D
    Acta Biomater; 2023 Mar; 159():338-352. PubMed ID: 36669551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.